Company
BioNexus Gene Lab Corp
BGLC · CIK 0001737523
Acquisition (code A) of 16,129 shares; price not stated (see filing).
Reporting Person Low Jook Yuen · Transaction Code A
Traded Aug 13, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001520138-26-000345 · filed 2026-08-14 · View filing →
Acquisition (code A) of 96,774 shares; price not stated (see filing).
Reporting Person Chong Set Fui · Officer Title Chief Financial Officer · Transaction Code A
Traded Aug 13, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001520138-26-000346 · filed 2026-08-14 · View filing →
Acquisition (code A) of 32,258 shares; price not stated (see filing).
Reporting Person Bin Abdul Hamid Muhammad Azrul · Transaction Code A
Traded Aug 13, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001520138-26-000347 · filed 2026-08-14 · View filing →
Acquisition (code A) of 32,258 shares; price not stated (see filing).
Reporting Person Yap Chee Keong · Transaction Code A
Traded Aug 13, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001520138-26-000348 · filed 2026-08-14 · View filing →
Acquisition (code A) of 338,709 shares; price not stated (see filing).
Reporting Person Tan Lee Su-Leng · Officer Title Chief Executive Officer · Transaction Code A
Traded Aug 13, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001520138-26-000349 · filed 2026-08-14 · View filing →